Dr Agarwal's Health [AGARWALEYE] vs Shree Pacetronix [SHREEPAC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Dr Agarwal's Health Care Ltd wins in 6 metrics, Shree Pacetronix Ltd. wins in 12 metrics, with 0 ties. Shree Pacetronix Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dr Agarwal's Health Care Ltd | Shree Pacetronix Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 109.80 | 20.75 | Shree Pacetronix Ltd. |
| Price-to-Book Ratio | 7.17 | 3.24 | Shree Pacetronix Ltd. |
| Debt-to-Equity Ratio | 48.68 | 32.04 | Shree Pacetronix Ltd. |
| PEG Ratio | 77.92 | -0.14 | Dr Agarwal's Health Care Ltd |
| EV/EBITDA | 30.74 | 12.06 | Shree Pacetronix Ltd. |
| Profit Margin (TTM) | 6.38% | 12.10% | Shree Pacetronix Ltd. |
| Operating Margin (TTM) | 14.22% | 6.16% | Dr Agarwal's Health Care Ltd |
| EBITDA Margin (TTM) | 14.22% | 6.16% | Dr Agarwal's Health Care Ltd |
| Return on Equity | 4.33% | 5.44% | Shree Pacetronix Ltd. |
| Return on Assets (TTM) | 2.27% | 3.25% | Shree Pacetronix Ltd. |
| Free Cash Flow (TTM) | $394.30M | $-72,464 | Dr Agarwal's Health Care Ltd |
| 1-Year Return | 17.19% | 73.55% | Shree Pacetronix Ltd. |
| Price-to-Sales Ratio (TTM) | 7.03 | 2.59 | Shree Pacetronix Ltd. |
| Enterprise Value | $144.88B | $547.67M | Dr Agarwal's Health Care Ltd |
| EV/Revenue Ratio | 7.33 | 2.67 | Shree Pacetronix Ltd. |
| Gross Profit Margin (TTM) | 62.87% | 69.97% | Shree Pacetronix Ltd. |
| Revenue per Share (TTM) | $63 | $57 | Dr Agarwal's Health Care Ltd |
| Earnings per Share (Diluted) | $3.99 | $6.84 | Shree Pacetronix Ltd. |
| Beta (Stock Volatility) | N/A | -0.98 | N/A |
Dr Agarwal's Health Care Ltd vs Shree Pacetronix Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dr Agarwal's Health Care Ltd | -0.10% | -2.72% | -2.40% | 3.65% | -11.79% | -12.18% |
| Shree Pacetronix Ltd. | 2.61% | -0.39% | 4.04% | 31.20% | -46.19% | -22.04% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dr Agarwal's Health Care Ltd | 17.19% | 9.38% | 9.38% | 9.38% | 9.38% | 9.38% |
| Shree Pacetronix Ltd. | 73.55% | -37.38% | 1,403.82% | 743.43% | 289.00% | 1,913.14% |
Performance & Financial Health Analysis: Dr Agarwal's Health Care Ltd vs Shree Pacetronix Ltd.
| Metric | AGARWALEYE | SHREEPAC |
|---|---|---|
| Market Information | ||
| Market Cap | ₹138.86B | ₹532.08M |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 98,862 | 4,031 |
| 90 Day Avg. Volume | 169,210 | 4,292 |
| Last Close | ₹439.30 | ₹141.50 |
| 52 Week Range | ₹371.50 - ₹568.00 | ₹66.10 - ₹283.15 |
| % from 52W High | -22.66% | -50.03% |
| All-Time High | ₹568.00 (Oct 16, 2025) | ₹391.90 (Nov 06, 2023) |
| % from All-Time High | -22.66% | -63.89% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.23% | 0.20% |
| Quarterly Earnings Growth | 0.51% | 0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.12% |
| Operating Margin (TTM) | 0.14% | 0.06% |
| Return on Equity (TTM) | 0.04% | 0.05% |
| Debt to Equity (MRQ) | 48.68 | 32.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹61.13 | ₹43.78 |
| Cash per Share (MRQ) | ₹12.58 | ₹3.55 |
| Operating Cash Flow (TTM) | ₹1.43B | ₹-25,029 |
| Levered Free Cash Flow (TTM) | ₹834.60M | ₹7.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Dr Agarwal's Health Care Ltd vs Shree Pacetronix Ltd.
| Metric | AGARWALEYE (Apr 26, 2026) | SHREEPAC (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 109.80 | 20.75 |
| Forward P/E | 77.92 | N/A |
| PEG Ratio | 77.92 | -0.14 |
| Price to Sales (TTM) | 7.03 | 2.59 |
| Price to Book (MRQ) | 7.17 | 3.24 |
| Market Capitalization | ||
| Market Capitalization | ₹138.86B | ₹532.08M |
| Enterprise Value | ₹144.88B | ₹547.67M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.33 | 2.67 |
| Enterprise to EBITDA | 30.74 | 12.06 |
| Risk & Other Metrics | ||
| Beta | N/A | -0.98 |
| Book Value per Share (MRQ) | ₹61.13 | ₹43.78 |
Financial Statements Comparison: Dr Agarwal's Health Care Ltd vs Shree Pacetronix Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | AGARWALEYE (2025) | SHREEPAC (2025) |
|---|---|---|
| Revenue/Sales | 17.05B | 168.03M |
| Cost of Goods Sold | 9.36B | 65.81M |
| COGS % of Revenue | 54.9% | 39.2% |
| Gross Profit | 7.69B | 102.22M |
| Gross Margin | 45.1% | 60.8% |
| Research & Development | N/A | 4.42M |
| Operating Income (EBIT) | 2.49B | 15.31M |
| Operating Margin | 14.6% | 9.1% |
| EBITDA | 4.91B | 24.33M |
| EBITDA Margin | 28.8% | 14.5% |
| Pre-Tax Income | 1.60B | 10.43M |
| Pre-Tax Income % of Revenue | 9.4% | 6.2% |
| Income Tax | 495.10M | 2.93M |
| Income Tax % of Revenue | 2.9% | 1.7% |
| Net Income (Profit) | 1.10B | 7.50M |
| Profit Margin | 6.5% | 4.5% |
Balance Sheet & Liquidity Metrics
| Metric | AGARWALEYE (2025) | SHREEPAC (2025) |
|---|---|---|
| Cash & Equivalents | 1.04B | 1.78M |
| Total Current Assets | 7.94B | 171.89M |
| Total Current Assets % of Revenue | 46.6% | 102.3% |
| Total Current Liabilities | 4.78B | 88.66M |
| Total Current Liabilities % of Revenue | 28.0% | 52.8% |
| Long-Term Debt | 8.08B | 3.61M |
| Long-Term Debt % of Revenue | 47.4% | 2.1% |
| Total Shareholders Equity | 19.27B | 137.82M |
| Retained Earnings | -1.85B | 94.54M |
| Retained Earnings % of Revenue | -10.9% | 56.3% |
| Property, Plant & Equipment | 6.60B | 245,392 |
Cash Flow Statement Comparison
| Metric | AGARWALEYE (2025) | SHREEPAC (2025) |
|---|---|---|
| Operating Cash Flow | 1.43B | -25,029 |
| Operating Cash Flow % of Revenue | 8.4% | 0.0% |
| Capital Expenditures | 5.30M | -71,674 |
| Free Cash Flow | 394.30M | -72,464 |
| FCF Margin | 2.3% | 0.0% |
| Debt Repayment | -2.03B | -1.84M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AGARWALEYE | SHREEPAC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 316.96M | 3.75M |
| Float Shares | 60.08M | 918,023 |
| % Held by Insiders | 75.49% | 66.74% |
| % Held by Institutions | 16.46% | 0.00% |
| % Held by Public | 8.05% | 33.26% |
Dividend Analysis & Yield Comparison: Dr Agarwal's Health Care Ltd vs Shree Pacetronix Ltd.
| Metric | AGARWALEYE | SHREEPAC |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |